Substrate specificity of 6-O-endosulfatase (Sulf-2) and its implications in synthesizing anticoagulant heparan sulfate

Glycobiology

Volumn 22, Issue 10, 2012, Pages 1353-1362

  Pempe, Elizabeth H ^a   Burch, Tanya C ^a   Law, Courtney J ^a   Liu, Jian ^a  

^a University of North Carolina   (United States)

Author keywords

heparan sulfate; heparin; substrate specificity; sulfatase

Indexed keywords

ANTITHROMBIN; DISACCHARIDE; GLUCOSAMINE DERIVATIVE; HEPARAN SULFATE; POLYSACCHARIDE SULFATE; PROTEIN 6 O ENDOSULFATASE; RECOMBINANT ENZYME; SULFATASE; THROMBOCYTE FACTOR 4; UNCLASSIFIED DRUG; URONIC ACID;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENETIC TRANSFECTION; HEPARIN INDUCED THROMBOCYTOPENIA; ISOTOPE LABELING; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

ANTICOAGULANTS; BIOCATALYSIS; HEPARITIN SULFATE; HUMANS; HYDROLYSIS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; SULFOTRANSFERASES;

CRICETULUS GRISEUS;

EID: 84865480913     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws092     Document Type: Article

References (45)

1. Ai X, Do AT, Lozynska O, Kusche-Gullberg M, Lindahl U, Emerson CP, Jr. 2003. QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol. 162:341-351. (Pubitemid 36928846)
2. Ai X, Do AT, Kusche-Gullberg M, Lindahl U, Lu K, Emerson CP, Jr. 2006. Substrate specificity and domain functions of extracellular heparan sulfate 6-O-endosulfatases, QSulf1 and QSulf2. J Biol Chem. 281:4969-4976. (Pubitemid 43847759)
3. Ai X, Kitazawa T, Do AT, Kusche-Gullberg M, Labosky PA, Emerson CP, Jr. 2007. SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation. Development. 134:3327-3338. (Pubitemid 350018433)
4. Arepally GM, Ortel TL. 2010. Heparin-induced thrombocytopenia. Annu Rev Med. 61:77-90.
5. Atha DH, Lormeau JC, Petitou M, Rosenberg RD, Choay J. 1985. Contribution of monosaccharide residues in heparin binding to antithrombin III. Biochemistry. 24:6723-6729. (Pubitemid 16207156)
6. Chen J, Jones CL, Liu J. 2007. Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures. Chem Biol. 14:986-993. (Pubitemid 47404901)
7. Colliec-Jouault S, Shworak NW, Liu J, De Agostini AI, Rosenberg RD. 1994. Characterization of a cell mutant specifically defective in the synthesis of anticoagulantly active heparan sulfate. J Biol Chem. 271:24953-24958.
8. Dai Y, Yang Y, MacLeod V, Yue X, Rapraeger AC, Shriver Z, Venkataraman G, Sasisekharan R, Sanderson RD. 2005. HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. J Biol Chem. 280:40066-40073. (Pubitemid 41779141)
9. Danenberg HD, Szalai AJ, Swaminathan RV, Peng L, Chen Z, Seifert P, Fay WP, Simon DI, Edelman ER. 2003. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation. 108:512-515. (Pubitemid 36961161)
10. Dhoot GK, Gustafsson MK, Ai X, Sun W, Standiford DM, Emerson CP, Jr. 2001. Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science. 293:1663-1666. (Pubitemid 32807846)
11. Duncan MB, Liu M, Fox C, Liu J. 2006. Characterization of the N-deacetylase domain from the heparan sulfate N-deacetylase/N-sulfotransferase 2. Biochem Biophys Res Commun. 339:1232-1237. (Pubitemid 41790595)
12. Esko JD, Selleck SB. 2002. Order out of chaos: Assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem. 71:435-471. (Pubitemid 34800227)
13. Feyerabend TB, Li JP, Lindahl U, Rodewald HR. 2006. Heparan sulfate C5-epimerase is essential for heparin biosynthesis in mast cells. Nat Chem Biol. 2:195-196.
14. Guerrini M, Shriver Z, Bisio A, Naggi A, Casu B, Sasisekharan R, Torri G. 2009. The tainted heparin story: An update. Thromb Haemost. 102:907-911.
15. Holst CR, Bou-Reslan H, Gore BB, Wong K, Grant D, Chalasani S, Carano RA, Frantz GD, Tessier-Lavigne M, Bolon B. 2007. Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival. PLoS One. 2:e575.
16. Lai JP, Chien JR, Moser DR, Staub JK, Aderca I, Montoya DP, Matthews TA, Nagorney DM, Cunningham JM, Smith DI. 2004. HSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparinbinding growth factor signaling. Gastroenterology. 126:231-248. (Pubitemid 38040739)
17. Lai JP, Sandhu DS, Yu C, Han T, Moser CD, Jackson KK, Guerrero RB, Aderca I, Isomoto H, Garrity-Park MM. 2008. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma. Hepatology. 47:1211-1222. (Pubitemid 351547907)
18. Lamanna WC, Kalus I, Padva M, Baldwin RJ, Merry CL, Dierks T. 2007. The heparanome-the enigma of encoding and decoding heparan sulfate. J Biotechnol. 129:290-307. (Pubitemid 46529030)
19. Lee MK, Lander AD. 1991. Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: Development of a sensitive electrophoretic approach. Proc Natl Acad Sci USA. 88: 2768-2772. (Pubitemid 21916500)
20. Lemjabbar-Alaoui H, van Zante A, Singer MS, Xue Q, Wang YQ, Tsay D, He B, Jablons DM, Rosen SD. 2010. Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis. Oncogene. 29:635-646.
21. Lind T, Tufaro F, McCormick C, Lindahl U, Lidholt K. 1998. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem. 273:26265-26268. (Pubitemid 28471622)
22. Lindahl U, Kusche-Gullberg M, Kjellen L. 1998. Regulated diversity of heparan sulfate. J Biol Chem. 273:24979-24982. (Pubitemid 28443251)
23. Liu J, Shworak NW, Fritze LMS, Edelberg JM, Rosenberg RD. 1996. Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. J Biol Chem. 271:27072-27082. (Pubitemid 26359127)
24. Liu J, Shworak NW, Sinaÿ P, Schwartz JJ, Zhang L, Fritze LMS, Rosenberg RD. 1999. Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities. J Biol Chem. 274:5185-5192.
25. Lum DH, Tan J, Rosen SD, Werb Z. 2007. Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2. Mol Cell Biol. 27: 678-688. (Pubitemid 46080133)
26. Mikhailov D, Young HC, Linhardt RJ, Mayo KH. 1999. Heparin dodecasaccharide binding to platelet factor-4 and growth-related protein-alpha. J Biol Chem. 274:25317-25329.
27. Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD. 2002. Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem. 277:49175-49185. (Pubitemid 36014346)
28. Nagamine S, Koike S, Keino-Masu K, Masu M. 2005. Expression of a heparan sulfate remodeling enzyme, heparan sulfate 6-O-endosulfatase sulfatase FP2, in the rat nervous system. Brain Res Dev Brain Res. 159:135-143. (Pubitemid 41338323)
29. Nawroth R, van Zante A, Cervantes S, McManus M, Hebrok M, Rosen SD. 2007. Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells. PLoS One. 2:e392.
30. Ohto T, Uchida H, Yamazaki H, Keino-Masu K, Matsui A, Masu M. 2002. Identification of a novel nonlysosomal sulphatase expressed in the floor plate, choroid plexus and cartilage. Genes Cells. 7:173-185. (Pubitemid 34213362)
31. Peterson S, Frick A, Liu J. 2009. Designing of biologically active heparan sulfate and heparin using an enzyme-based approach. Nat Prod Rep. 26:61-627.
32. Peterson SB, Liu J. 2010. Unraveling the specificity of heparanase utilizing synthetic substrates. J Biol Chem. 285:14504-14513.
33. Phillips JJ, Huillard E, Robinson AE, Ward A, Lum DH, Polley MY, Rosen SD, Rowitch DH, Werb Z. 2012. Heparan sulfate sulfatase SULF2 regulates PDGFRalpha signaling and growth in human and mouse malignant glioma. J Clin Invest. 122:911-922.
34. Ratzka A, Kalus I, Moser M, Dierks T, Mundlos S, Vortkamp A. 2008. Redundant function of the heparan sulfate 6-O-endosulfatases Sulf1 and Sulf2 during skeletal development. Dev Dyn. 237:339-353. (Pubitemid 351312107)
35. Rosen SD, Lemjabbar-Alaoui H. 2010. Sulf-2: An extracellular modulator of cell signaling and a cancer target candidate. Expert Opin Ther Targets. 14:935-949.
36. Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L. 1997. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest. 100:S67-S75. (Pubitemid 28009550)
37. Saad OM, Leary JA. 2003. Compositional analysis and quantification f heparin and heparan sulfate by electrospray ionization ion trap mass spectrometry. Anal Chem. 75:2985-2995. (Pubitemid 36830424)
38. Shively JE, Conrad HE. 1976. Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry. 15:3932-3942.
39. Tang R, Rosen SD. 2009. Functional consequences of the subdomain organization of the sulfs. J Biol Chem. 284:21505-21514.
40. Taylor KR, Gallo RL. 2006. Glycosaminoglycans and their proteoglycans: Host-associated molecular patterns for initiation and modulation of inflammation. FASB J. 20:9-22. (Pubitemid 43100470)
41. Turnbull J, Powell A, Guimond S. 2001. Heparan sulfate: Decoding a dynamic multifunctional cell regulator. Trends Cell Biol. 11:75-82. (Pubitemid 32144754)
42. Vann WF, Schmidt MA, Jann B, Jann K. 1981. The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010: K5:H4. Eur J Biochem. 116:359-364. (Pubitemid 11039072)
43. Viviano BL, Paine-Saunders S, Gasiunas N, Gallagher J, Saunders S. 2004. Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist Noggin. J Biol Chem. 279:5604-5611. (Pubitemid 38220587)
44. Yue X, Li X, Nguyen HT, Chin DR, Sullivan DE, Lasky JA. 2008. Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo. J Biol Chem. 283: 20397-20407.
45. Zhang L, Beeler DL, Lawrence R, Lech M, Liu J, Davis JC, Shriver Z, Sasisekharan R, Rosenberg RD. 2001. 6-O-sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway. J Biol Chem. 276:42311-42321.